ArticleMDM policy & practice

A Cost-Effectiveness Analysis of Diffuse Large B-Cell Lymphoma Treatment Pathways in the United States.

Anik R Patel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.